AC Immune SA

ACIUNASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
2.25 USD
↘ 0.15 (6.25%)AT CLOSE (11:59 AM EDT)
2.38
↗ 0.13 (5.56%)
POST MARKET (AS OF 07:50 PM EDT)
Post Market
AS OF 07:50 PM EDT
2.38
↗ 0.13 (5.56%)
🔴Market: CLOSED
Open?$2.39
High?$2.46
Low?$2.22
Prev. Close?$2.40
Volume?328.1K
Avg. Volume?N/A
VWAP?$2.29
Bid / Ask
Bid?$2.32 × 500
Ask?$2.50 × 2.0K
Spread?$0.18
Midpoint?$2.41
Valuation & Ratios
Market Cap?229.0M
Shares Out?101.8M
Float?62.7M
Float %?61.6%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A

AC Immune SA (ACIU) trades at $2.25 per share. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
Themes
Biotech - Drug Development›Neuroscience & CNSLongevity & Aging›Age-Related TherapeuticsHealthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
122
Market Cap
229.0M
Industry
N/A
Website
www.acimmune.com
Listed
2016-09-23
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
31
Piotroski F-Score?0/9Weak
Altman Z-Score?-10.20Distress
Confidence?44%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?5.15%Elevated
Short Interest?3.2M
Days to Cover?10.1
Free Float62.7M
Avg Daily Volume318.7K
Settlement Date2026-05-15
MarketsMoversWatchlist